IBT receives additional funding from BioGaia

Infant Bacterial Therapeutics plans to start a study on the safety and tolerability of the product in 2015. To allow for the study start, BioGaia will support IBT with an additional investment of 520 000 US dollars.

Read the official IBT press release here
Read the official BioGaia press release here

March 26, 2015